You are here

  • Home
  • Archive
  • Volume 12, Issue 4
  • Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

Article metrics

Article menu
Position article and guidelines
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy

 

Online download statistics by month:

Online download statistics by month: April 2024 to June 2025

AbstractFullPdf
Apr 2024855868442
May 2024298300194
Jun 2024234237142
Jul 2024244245120
Aug 2024271268124
Sep 2024236235135
Oct 2024191194112
Nov 202419019497
Dec 2024260265119
Jan 2025169169107
Feb 2025241241109
Mar 2025242243201
Apr 2025208208125
May 2025204204152
Jun 2025130130100
Total397340012279